A Primary Care Approach to Myelodysplastic Syndromes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Myelodysplastic syndromes (MDS) are probably the most common hematologic malignancies in adults over the age of 60 and are a major source of morbidity and mortality among older age groups. Diagnosis and management of this chronic blood cancer has evolved significantly in recent years and there are Food and Drug Administration-approved therapies that can extend patients’ life expectancy and improve quality of life. Primary care physicians (PCPs) are often involved in the process of diagnosis and follow-up of MDS patients, especially those in low-risk groups. They can therefore play an important role in improving patient care and quality of life by ensuring early referral and participating in supportive management. There is also a shortage of oncologists which increases the importance of the role of PCPs in management of MDS patients. In the face of limited resources, PCPs can improve access and quality of care in MDS patients. This article provides an overview of the common manifestations, diagnostic approaches, and therapeutic modalities of MDS for PCPs, with a focus on when to suspect MDS, when a referral is appropriate, and how to provide appropriate supportive care for patients diagnosed with MDS.
Abstract
Myelodysplastic syndromes (MDS) are probably the most common hematologic malignancies in adults over the age of 60 and are a major source of morbidity and mortality among older age groups. Diagnosis and management of this chronic blood cancer has evolved significantly in recent years and there are Food and Drug Administration-approved therapies that can extend patients’ life expectancy and improve quality of life. Primary care physicians (PCPs) are often involved in the process of diagnosis and follow-up of MDS patients, especially those in low-risk groups. They can therefore play an important role in improving patient care and quality of life by ensuring early referral and participating in supportive management. There is also a shortage of oncologists which increases the importance of the role of PCPs in management of MDS patients. In the face of limited resources, PCPs can improve access and quality of care in MDS patients. This article provides an overview of the common manifestations, diagnostic approaches, and therapeutic modalities of MDS for PCPs, with a focus on when to suspect MDS, when a referral is appropriate, and how to provide appropriate supportive care for patients diagnosed with MDS.
참고문헌 (29)
- Newman K, "Revisiting use of growth factors in myelodysplastic syndromes", Asian Pac J Cancer Prev, 13, pp.1081~1091 (2012)
- Barzi A, "Myelodysplastic syndromes: a practical approach to diagnosis and treatment", Cleve Clin J Med, 77, pp.37~44 (2010)
- Erikson C, "Future supply and demand for oncologists: challenges to assuring access to oncology services", J Oncol Pract, 3, pp.79~86 (2007)
- Klabunde CN, "The role of primary care physicians in cancer care", J Gen Intern Med, 24, pp.1029~1036 (2009)
- Iwanaga M, "Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors", J Clin Oncol, 29, pp.428~434 (2011)
- Strom SS, "Risk factors of myelodysplastic syndromes: a case-control study", Leukemia, 19, pp.1912~1918 (2005)
- Ma X, "Myelodysplastic syndromes: incidence and survival in the United States", Cancer, 109, pp.1536~1542 (2007)
- Rowley JD, "International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report", Genes Chromosomes Cancer, 33, pp.331~345 (2002)
- Godley LA, "Therapy-related myeloid leukemia", Semin Oncol, 35, pp.418~429 (2008)
- Williamson PJ, "Establishing the incidence of myelodysplastic syndrome", Br J Haematol, 87, pp.743~745 (1994)
- Butturini A, "Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study", Blood, 84, pp.1650~1655 (1994)
- Chen B, "Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries", Leukemia, 19, pp.767~775 (2005)
- Lee JH, "Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome", Leukemia, 17, pp.305~313 (2003)
- Steensma DP, "The myelodysplastic syndromes: diagnosis and treatment", Mayo Clin Proc, 81, pp.104~130 (2006)
- Zhou J, "Myelodysplastic syndromes", Semin Diagn Pathol, 28, pp.258~272 (2011)
- Guralnik JM, "Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia", Blood, 104, pp.2263~2268 (2004)
- Steensma DP, "Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors", Curr Hematol Malig Rep, 7, pp.310~320 (2012)
- Akhtari M, "When to treat myelodysplastic syndromes", Oncology (Williston Park), 25, pp.480~486 (2011)
- Jadersten M, "Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion", Haematologica, 95, pp.348~351 (2010)
- Valent P, "Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference", Leuk Res, 31, pp.727~736 (2007)
- Greenberg PL, "Revised international prognostic scoring system for myelodysplastic syndromes", Blood, 120, pp.2454~2465 (2012)
- Sekeres MA, "Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys", J Natl Cancer Inst, 100, pp.1542~1551 (2008)
- List A, "Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion", N Engl J Med, 355, pp.1456~1465 (2006)
- Liumbruno G, "Recommendations for the transfusion of red blood cells", Blood Transfus, 7, pp.49~64 (2009)
- Messa E, "Iron chelation therapy in myelodysplastic syndromes", Adv Hematol, 2010, pp.756289~ (2010)
- Akhtari M, "Twenty years of G-CSF: clinical and nonclinical discoveries", pp.183~193 (2012), Springer
- Slichter SJ, "Evidence-based platelet transfusion guidelines", Hematology Am Soc Hematol Educ Program, 2007, pp.172~178 (2007)
- Oeffinger KC, "Models for delivering survivorship care", J Clin Oncol, 24, pp.5117~5124 (2006)
- Hong S, "Cancer survivorship care: exploring the role of the general internist", J Gen Intern Med, 24(Suppl 2), pp.S495~S500 (2009)